Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVER trial of sodium valproate for high-risk oral epithelial dysplasia
ISRCTN12448611Phase 2Active, not recruiting
- Sponsor
- University of Liverpool
- Start
- Oct 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of valproic acid in oral dysplasia (OED) (2 arms), sponsored by University of Liverpool. Primary endpoint: Disease response rate. Started Oct 2019; status: active, not recruiting.
02
Drugs
valproic acid
03
Conditions
oral dysplasia (OED)
Beyond the preview
Go deeper on ISRCTN12448611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12448611.